Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Medarex

Medarex is an integrated monoclonal antibody-based company with antibody discovery, development and manufacturing capabilities. Utilizing its HuMAb-Mouse(TM) system, Medarex has the ability to make fully-human antibodies in a transgenic mouse whose mouse genes for creating antibodies have been inactivated and replaced by human antibody genes. The Company has entered into ten corporate partnering arrangements based on the HuMAb-Mouse system.


Contact Details:
707 State Road #206
Princeton
NJ
08540
United States of America
Tel:(609) 430-2880
Fax:609-430-2850
Email:information@medarex.com
WWW:

www.medarex.com/




Loading...

Recent Publications by Medarex:

Identification and measurement of isoaspartic acid formation in the complementarity determining region of a fully human monoclonal antibody.
Isomerization plays a key role in protein degradation. This isomerization...
13th October, 2009
Analytical and Formulation Development Department, Medarex, Inc., 519 J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Nov 15;877(30):3841-9.
DOI Direct Link
Detection of apoptosis in mammalian development.
Mammalian development is dependent on an intricate orchestration of cell...
9th October, 2009
Medarex Inc, Bloomsbury, NY, USA. Methods Mol Biol. 2009;559:259-72.
DOI Direct Link
Isomerization in the CDR2 of a monoclonal antibody: Binding analysis and factors that influence the isomerization rate.
Isomerization of a monoclonal antibody is one of the common routes of...
7th October, 2009
Analytical and Formulation Development Department, Medarex, Inc., 519 Biotechnol Bioeng. 2009 Oct 5.
DOI Direct Link
A nonfucosylated human antibody to CD19 with potent B-cell depletive activity for therapy of B-cell malignancies.
A human anti-CD19 antibody was expressed in fucosyltransferase-deficient...
7th August, 2009
Department of Cell Biology and Pharmacology, Medarex, 1324 Chesapeake Cancer Immunol Immunother. 2009 Aug 6.
DOI Direct Link
In vitro and in vivo characterization of MDX-1401 for therapy of malignant lymphoma.
PURPOSE: This study was undertaken to evaluate the effects of MDX-1401, a...
4th August, 2009
Department of Cell Biology and Pharmacology, Medarex, Sunnyvale, CA 94089, Clin Cancer Res. 2009 May 15;15(10):3376-83. Epub 2009 Apr 28.
DOI Direct Link

View more Medarex research publications.

Press Releases on Medarex:

BioPortfolio Logo
Reportlinker Adds Monoclonal Antibody Therapies 2007: Competitive Landscape and Pipeline Insight 5th November, 2009 Reportlinker
NEW YORK, Nov. 5 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Monoclonal Antibody Therapies 2007: Competitive Landscape and Pipeline
Reportlinker Adds Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment 26th October, 2009 Reportlinker
-- A focus on "engineered" antibodies Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment reviews the broad drug development effort that is focused on bringing
GENova appoints Dr. Philip Gould to Scientific Advisory Board 13th September, 2009 GENova Biotherapeutics, Inc.
NEW YORK, NY, Sept. 13 /PRNewswire-FirstCall/ - (OTCBB: GVBP.OB) - GENova Biotherapeutics, Inc., ("GENova"), a biotechnology company that identifies, acquires, and develops novel drug
GENova names Dr. John Savin as Vice President 4th September, 2009 GENova Biotherapeutics, Inc.
NEW YORK, NY, Sept. 4 /PRNewswire-FirstCall/ - (OTCBB: GVBP.OB) - GENova Biotherapeutics, Inc., ("GENova"), a biotechnology company that identifies, acquires, and develops novel drug targets
New Report Just Published: World Multiple Myeloma Therapeutics Market Report 7th July, 2009 Reportlinker
NEW YORK, July 7 /PRNewswire/ -- Reportlinker.com just added a new market research report to its catalogue. World Multiple Myeloma Therapeutics Market http://www.reportlinker.com/p0119496/World

BioNews Results for Medarex:

ImmunoGen Discloses Board Appointments and Results of Shareholders Meeting
TradingMarkets:  Nov 17 2009 5:30AM Matching: medarex
ImmunoGen, Inc. Announces Election of Howard Pien to its Board of Directors and Other Results from its Annual
Pharma Live:  Nov 16 2009 2:45PM Matching: medarex
Bristol-Myers, Armed With More Cash, Ready To Make Deals
CNN Money:  Nov 12 2009 5:30PM Matching: medarex
Bristol-Myers, Armed With More Cash, Ready To Make Deals
Nasdaq:  Nov 12 2009 5:25PM Matching: medarex
Bristol-Myers, Armed With More Cash, Ready To Make Deals
Morningstar.com:  Nov 12 2009 5:24PM Matching: medarex
Promote your company here: BioNewsCast - Press Release Distribution

View more Medarex news.

Medarex Clinical Trials:

Comparison Study of MDX-010 (CTLA-4) Alone and Combined With DTIC in the Treatment of Metastatic Melanoma

Medarex Patents:

US Patent No.Title
6096311 Methods for use of monoclonal antibodies specific for the high affinity Fc receptor for immunoglobulin G
6962981 Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
6984720 Human CTLA-4 antibodies
6989452 Disulfide prodrugs and linkers and stabilizers useful therefor
7041870 Transgenic transchromosomal rodents for making human antibodies

View more Medarex patents.

Medarex (MEDX) Financial information Links from Barchart

MEDX Quote from from Barchart.com
MEDX Chart from from Barchart.com
MEDX Profile from from Barchart.com
MEDX Opinion from from Barchart.com

View more Medarex finance information.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 12 individuals from Medarex using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 852 times since April 2007, the link to the organisation's website has been followed 95 times

Recent Search Terms used to find this page: medarex mouse | Medarex USA | Medarex USA | medarex publications | medarex address | discovery research medarex tel no. | Medarex USA | mdx 1338 | medarex myeloma | Medarex Mouse | .

Search for more companies in Princeton

Search for more companies in NJ



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Medarex

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.